Wellmarker Bio DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Virtual Booth

Contact Supplier

Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

1 News #PharmaBuzz

media
1 News #PharmaBuzz

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Wellmarker Bio Co., Ltd., which spin-off from Asan Hospital in Seoul, has its own distinctive features: development of new drugs that consider unmet medical demand based on abundant hospital-based clinical data, and biomarker technology for predicting treatment response to this. Wellmarker Bio, an innovative new drug development company consisting of Target Discovery Research Center, Drug Discovery Research Center, Pharmaceutical Chemistry Research Center, and CMC Research Center, will contribute to the healthy life of humanity around the world through the development of new drugs based on biomarker predicting treatment response.